文献速递呼吸道感染呼吸危重症与机械通气

危重症COVID-19患者的不同临床亚表型识别

Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19.
PubMed 文献 · Chest · 2021-05-06

该多中心队列研究纳入美国67家医院的危重症COVID-19患者,通过潜在类别分析在发现队列和复制队列中独立识别亚表型,并分析其与28天死亡率的关系。结果识别出4种临床特征一致的亚表型,各亚表型28天死亡率不同,且校正混杂因素后仍存在差异。

要点

  • 危重症COVID-19可识别出4种临床特征一致的亚表型。
  • SP1以休克、酸血症和多器官功能障碍为特征,28天死亡率最高。
  • 各亚表型28天死亡率存在差异,且校正混杂因素后仍持续。

核心结论

  • 危重症COVID-19存在4种具有不同临床特征、合并症负担和死亡率的亚表型。

研究设计与样本

  • 多中心队列研究,纳入美国67家医院的危重症COVID-19患者。
  • 将中心随机分为发现队列(45家中心,n=2188)和复制队列(22家中心,n=1112)。
  • 在各自队列中独立使用潜在类别分析识别亚表型。
  • 分析亚表型与28天死亡率的关联。

主要发现

  • 发现队列识别出4种亚表型(SP1-SP4),在复制队列中特征一致。
  • SP1以休克、酸血症和多器官功能障碍(包括需肾脏替代治疗的急性肾损伤)为特征。
  • SP2以高C反应蛋白、早期需要机械通气和最高ARDS发生率为特征。
  • SP3慢性病负担最高,SP4慢性病负担有限且生理异常轻微。
  • 发现队列28天死亡率从SP4的20.6%到SP1的52.9%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Subphenotypes have been identified in patients with sepsis and ARDS and are associated with different outcomes and responses to therapies. RESEARCH QUESTION: Can unique subphenotypes be identified among critically ill patients with COVID-19? STUDY DESIGN AND METHODS: Using data from a multicenter cohort study that enrolled critically ill patients with COVID-19 from 67 hospitals across the United States, we randomly divided centers into discovery and replication cohorts. We used latent class analysis independently in each cohort to identify subphenotypes based on clinical and laboratory variables. We then analyzed the associations of subphenotypes with 28-day mortality. RESULTS: Latent class analysis identified four subphenotypes (SP) with consistent characteristics across the discovery (45 centers; n = 2,188) and replication (22 centers; n = 1,112) cohorts. SP1 was characterized by shock, acidemia, and multiorgan dysfunction, including acute kidney injury treated with renal replacement therapy. SP2 was characterized by high C-reactive protein, early need for mechanical ventilation, and the highest rate of ARDS. SP3 showed the highest burden of chronic diseases, whereas SP4 demonstrated limited chronic disease burden and mild physiologic abnormalities. Twenty-eight-day mortality in the discovery cohort ranged from 20.6% (SP4) to 52.9% (SP1). Mortality across subphenotypes remained different after adjustment for demographics, comorbidities, organ dysfunction and illness severity, regional and hospital factors. Compared with SP4, the relative risks were as follows: SP1, 1.67 (95% CI, 1.36-2.03); SP2, 1.39 (95% CI, 1.17-1.65); and SP3, 1.39 (95% CI, 1.15-1.67). Findings were similar in the replication cohort. INTERPRETATION: We identified four subphenotypes of COVID-19 critical illness with distinct patterns of clinical and laboratory characteristics, comorbidity burden, and mortality.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Vasquez CR, Gupta S, Miano TA, et al. Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19. Chest. 2021. PMID: 33964301. doi:10.1016/j.chest.2021.04.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。